Natixis Advisors L.P. Reduces Stock Position in Bath & Body Works, Inc. (NYSE:BBWI)

Natixis Advisors L.P. reduced its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 21.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 75,983 shares of the company's stock after selling 21,162 shares during the period. Natixis Advisors L.P.'s holdings in Bath & Body Works were worth $3,278,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of BBWI. Darsana Capital Partners LP bought a new position in Bath & Body Works in the 3rd quarter worth approximately $76,050,000. Earnest Partners LLC boosted its holdings in Bath & Body Works by 1,055,015.7% in the 3rd quarter. Earnest Partners LLC now owns 1,276,690 shares of the company's stock worth $43,152,000 after buying an additional 1,276,569 shares during the period. Newport Trust Company LLC bought a new position in Bath & Body Works in the 3rd quarter worth approximately $24,721,000. Victory Capital Management Inc. boosted its holdings in Bath & Body Works by 339.0% in the 3rd quarter. Victory Capital Management Inc. now owns 638,806 shares of the company's stock worth $21,592,000 after buying an additional 493,297 shares during the period. Finally, Sound Shore Management Inc CT bought a new position in Bath & Body Works in the 3rd quarter worth approximately $13,424,000. 95.14% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

BBWI has been the topic of several recent analyst reports. Wells Fargo & Company increased their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock an "equal weight" rating in a research note on Wednesday, April 24th. Robert W. Baird increased their target price on shares of Bath & Body Works from $50.00 to $54.00 and gave the stock an "outperform" rating in a research note on Friday, March 1st. BMO Capital Markets increased their target price on shares of Bath & Body Works from $48.00 to $50.00 and gave the stock an "outperform" rating in a research note on Friday, March 1st. Evercore ISI increased their target price on shares of Bath & Body Works from $30.00 to $45.00 and gave the stock an "in-line" rating in a research note on Friday, March 1st. Finally, Piper Sandler increased their target price on shares of Bath & Body Works from $44.00 to $45.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 9th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $46.73.

Insiders Place Their Bets

In other news, insider Thomas E. Mazurek sold 4,285 shares of the company's stock in a transaction that occurred on Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total value of $209,493.65. Following the transaction, the insider now owns 45,992 shares in the company, valued at $2,248,548.88. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.19% of the company's stock.

Bath & Body Works Trading Up 0.6 %

Shares of BBWI stock traded up $0.27 during mid-day trading on Monday, reaching $47.82. The stock had a trading volume of 3,343,841 shares, compared to its average volume of 2,722,776. The stock's 50-day moving average price is $46.21 and its two-hundred day moving average price is $41.92. Bath & Body Works, Inc. has a 52-week low of $27.30 and a 52-week high of $50.34. The firm has a market capitalization of $10.75 billion, a PE ratio of 12.42, a price-to-earnings-growth ratio of 1.54 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The company had revenue of $2.91 billion for the quarter, compared to analysts' expectations of $2.84 billion. During the same quarter in the previous year, the company earned $1.86 earnings per share. Bath & Body Works's quarterly revenue was up .8% on a year-over-year basis. On average, equities research analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.